Kasi Pharma Distributors Private Limited, a active private limited company, was established on 21 February 2017 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999KA2017PTC100719. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 13 professional, Its leadership includes Srinivasan Rajneekanth (Director), Vadivelu Mudaliar Kasiamma (Director), Manjunath Narasimhan (Additional Director). Past directors included Srinivasan Rajneekanth, Harikrishnan Mudaliar Vadivelu. It holds ₹3.90 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No 266/B, 10Th Cross 1St N Block, Rajajinagar, Bangalore, Karnataka, 560010.
U74999KA2017PTC100719
100719
21 February 2017
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Kasi Pharma Distributors Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasan Rajneekanth | Director | 31 May 2023 | Current |
| Vadivelu Mudaliar Kasiamma | Director | 21 Feb 2017 | Current |
| Manjunath Narasimhan | Additional Director | 16 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 02 Jun 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kasi Pharma Distributors Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.2% increase. The company also saw a substantial improvement in profitability, with a 12.32% increase in profit. The company's net worth Soared by an impressive increase of 23.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Kasi Pharma Distributors had a promoter holding of 92.00% and a public holding of 8.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹39,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2017 | Others | ₹3.90 Cr | Open |
Explore comprehensive loan charge details -
Kasi Pharma Distributors has a workforce of 13 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kasi Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kasi Pharma Distributors's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Manjunath Narasimhan was appointed as a Additional Director was appointed as a Additional Director on 16 Jan 2025 & has been associated with this company since 10 months 14 days . was completed.
The activity Kasi Pharma Distributors Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Srinivasan Rajneekanth was appointed as a Director was appointed as a Director on 31 May 2023 & has been associated with this company since 2 years 6 months . was completed.
Kasi Pharma Distributors Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was recorded as a recent event.
The activity A charge with Others of Rs. 39.00 M registered on 10 Jul 2017 with Charge ID 100115228 was modified on 11 Apr 2022. was completed.
The activity A charge with Others amounted to Rs. 39.00 M with Charge ID 100115228 was registered on 10 Jul 2017. was completed.
The CIN of Kasi Pharma Distributors Private Limited is U74999KA2017PTC100719.
Kasi Pharma Distributors Private Limited is headquartered at No 266/B, 10Th Cross 1St N Block, Rajajinagar, Bangalore, Karnataka, 560010.
Kasi Pharma Distributors Private Limited was incorporated on 21 February 2017.
The current directors of Kasi Pharma Distributors Private Limited are
The primary industry of Kasi Pharma Distributors Private Limited is Trade.
Kasi Pharma Distributors Private Limited is unlisted.
The authorized capital of Kasi Pharma Distributors Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Kasi Pharma Distributors Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX